IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $28,684,230 | +74.6% | 1,520,097 | -40.7% | 0.17% | +16.9% |
| Q4 2017 | $16,432,000 | -20.1% | 2,563,489 | -4.6% | 0.14% | -15.0% |
| Q3 2017 | $20,567,000 | -4.1% | 2,688,489 | -10.8% | 0.17% | -10.7% |
| Q2 2017 | $21,439,000 | +83.7% | 3,015,353 | 0.0% | 0.19% | +96.8% |
| Q1 2017 | $11,669,000 | +89.7% | 3,015,353 | 0.0% | 0.10% | +58.3% |
| Q4 2016 | $6,151,000 | -23.9% | 3,015,353 | 0.0% | 0.06% | -17.8% |
| Q3 2016 | $8,081,000 | -13.0% | 3,015,353 | 0.0% | 0.07% | -24.7% |
| Q2 2016 | $9,287,000 | -75.5% | 3,015,353 | -32.3% | 0.10% | -75.8% |
| Q1 2016 | $37,935,000 | -37.2% | 4,452,445 | 0.0% | 0.40% | -20.2% |
| Q4 2015 | $60,420,000 | +77.4% | 4,452,445 | +25.5% | 0.50% | +59.0% |
| Q3 2015 | $34,061,000 | +2.1% | 3,548,040 | +52.9% | 0.32% | +7.5% |
| Q2 2015 | $33,368,000 | +273.0% | 2,320,424 | +132.2% | 0.29% | +295.9% |
| Q1 2015 | $8,945,000 | – | 999,496 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |